(Q67873050)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

title

Topical cyclosporine in vernal keratoconjunctivitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Topical Cyclosporine in Vernal Keratoconjunctivitis (English)

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

28 November 2022

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

28 November 2022

author name string

J. H. Bleik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1800929

28 November 2022

K. F. Tabbara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1800929

28 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1800929

28 November 2022

publication date

1 November 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

18 September 2019

https://api.elsevier.com/content/article/PII:S0161642091320694?httpAccept=text/plain

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

https://api.elsevier.com/content/article/PII:S0161642091320694?httpAccept=text/xml

28 November 2022

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

28 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

page(s)

1679-1684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

Cyclosporine: immunology, pharmacology and therapeutic uses

18 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Suppression of the allergic contact reaction in the guinea pig by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

[Local treatment of corneal transplants in the human with cyclosporin A]

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

In vitro immunosuppressive properties of cyclosporine metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Two types of human mast cells that have distinct neutral protease compositions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2891%2932069-4

7 January 2021

Mechanism of action of Cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas

2

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process

28 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection

28 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

Rabbit corneal allograft survival following topical administration of cyclosporin A

28 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/S0161-6420(91)32069-4

28 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1800929%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference